| RNA interference and nanotechnology: A promising alliance for next generation cancer therapeutics G Swaminathan, A Shigna, A Kumar, VV Byroju, VR Durgempudi, ... Frontiers in Nanotechnology 3, 694838, 2021 | 24 | 2021 |
| Combinatorial therapy using RNAi and curcumin nano-architectures regresses tumors in breast and colon cancer models A Kumar, A Singam, G Swaminathan, N Killi, NK Tangudu, J Jose, RG Vn, ... Nanoscale 14 (2), 492-505, 2022 | 20 | 2022 |
| LeukmiR: a database for miRNAs and their targets in acute lymphoblastic leukemia A Rawoof, G Swaminathan, S Tiwari, RA Nair, L Dinesh Kumar Database 2020, baz151, 2020 | 16 | 2020 |
| Inulin coated Mn3O4 nanocuboids coupled with RNA interference reverse intestinal tumorigenesis in Apc knockout murine colon cancer models K Kourani, P Jain, A Kumar, AK Jangid, G Swaminathan, VR Durgempudi, ... Nanomedicine: Nanotechnology, Biology and Medicine 40, 102504, 2022 | 10 | 2022 |
| Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer K Rubio, AJ Romero-Olmedo, P Sarvari, G Swaminathan, VP Ranvir, ... Theranostics 13 (8), 2384, 2023 | 7 | 2023 |
| 3D genome organization during TGFB-induced transcription requires nuclear microRNA and G-quadruplexes J Cordero, G Swaminathan, DG Rogel-Ayala, K Rubio, A Elsherbiny, ... bioRxiv, 2023.12. 22.573061, 2023 | 1 | 2023 |
| Implications in Cancer of Nuclear Micro RNAs, Long Non-Coding RNAs, and Circular RNAs Bound by PRC2 and FUS G Swaminathan, DG Rogel-Ayala, A Armich, G Barreto Cancers 16 (5), 868, 2024 | | 2024 |
| Acute Lymphoblastic Leukemia: Promising Technologies for the Management of the Disease G Swaminathan, V Byroju, A Kumar, K Kourani ResearchGate GmbH, 2021 | | 2021 |
Lekha Dinesh KumarCSIR-CCMBVerified email at ccmb.res.in
